Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antipsychotic agents: a review

S C Dilsaver1

  • 1Harris County Psychiatric Center, University of Texas Medical School, Houston.

American Family Physician
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Antipsychotic medications, categorized by potency, treat psychosis. Low-potency drugs cause anticholinergic effects, while high-potency agents may lead to extrapyramidal side effects and serious reactions like tardive dyskinesia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor antagonists at the GABA(A) receptor chloride-ionophore complex.

Neurochemistry international·2010
Same author

Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants.

Journal of affective disorders·2002
Same author

Unsuspected depressive mania in pre-pubertal Hispanic children referred for the treatment of 'depression' with history of social 'deviance'.

Journal of affective disorders·2002
Same author

ECT in mixed affective states: a case series.

The journal of ECT·2000
Same author

Mania: differential effects of previous depressive and manic episodes on response to treatment.

Acta psychiatrica Scandinavica·2000
Same author

Mania: gender, transmitter function, and response to treatment.

Psychiatry research·2000

Area of Science:

  • Pharmacology
  • Neuroscience
  • Psychiatry

Background:

  • Antipsychotic agents are crucial for managing psychosis in both functional and organic mental disorders.
  • These medications are broadly classified into low-potency and high-potency types based on their receptor-binding profiles.

Purpose of the Study:

  • To delineate the pharmacological differences between low- and high-potency antipsychotic agents.
  • To describe the characteristic side effects and serious reactions associated with each class of antipsychotics.

Main Methods:

  • Review of existing literature on antipsychotic drug mechanisms and clinical effects.
  • Classification of antipsychotics based on receptor affinity (muscarinic, alpha 1-adrenergic, dopamine).

Main Results:

Related Experiment Videos

  • Low-potency agents (e.g., chlorpromazine) block muscarinic and alpha 1-adrenergic receptors, leading to anticholinergic side effects and orthostatic hypotension.
  • High-potency agents exhibit greater affinity for dopamine receptors, often causing extrapyramidal side effects (dystonia, parkinsonism).
  • Serious adverse reactions, including tardive dyskinesia and neuroleptic malignant syndrome, are associated with antipsychotic drug use.

Conclusions:

  • The potency of antipsychotic agents dictates their receptor-binding profile and associated adverse effects.
  • Understanding these differences is vital for optimizing treatment and managing potential risks in patients with psychosis.